In the BCR/ABL1 positive MPN classification, chronic myeloid leukemia (CML) is responsible for 15–20% of leukemias worldwide, with an incidence of 1–2/100,000. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.